American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1
Lauren A. Henderson(Boston Children's Hospital), Jay Mehta(Sardar Patel University), Kate F. Kernan(Children's Hospital of Pittsburgh), David R. Karp(The University of Texas Southwestern Medical Center), Adriana H. Tremoulet(George Washington University Hospital), Hamid Bassiri(Johnson & Johnson (United States)), Rae S. M. Yeung(University of Toronto), Kevin G. Friedman(Boston Children's Hospital), Grant S. Schulert(Cincinnati Children's Hospital Medical Center), Edward M. Behrens(Children's Hospital of Philadelphia), Philip Seo(Johns Hopkins University), Mark Gorelik(Morgan Stanley Children's Hospital), Scott Canna(Children's Hospital of Philadelphia), Amy S. Mudano(University of Alabama at Birmingham), Amy S. Turner(American College of Rheumatology), Sivia Lapidus(Hackensack University Medical Center), Anne Ferris(Stollery Children's Hospital), Mary Beth F. Son(Boston Children's Hospital)
Cited by 537
Related Papers
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
|New England Journal of Medicine|2006|902